News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Heyman Tomas J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on OptiNose, Inc.|
Txns:
| Granted 53,500 options to buy
@ $1.18, valued at
$63.1k
|
|
| 06/02/2023 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on EXELIXIS, INC.|
Txns:
| Granted 18,176 shares
@ $0
Granted 36,353 options to buy
@ $19.28, valued at
$700.9k
|
|
| 06/02/2023 |
3
| Heyman Tomas J. (Director) has filed a Form 3 on EXELIXIS, INC. |
| 05/25/2023 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 09/16/2022 |
3
| Heyman Tomas J. (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 09/16/2022 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 26,400 options to buy
@ $3.15, valued at
$83.2k
|
|
| 06/24/2022 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $3.09, valued at
$231.8k
|
|
| 06/09/2022 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on OptiNose, Inc.|
Txns:
| Granted 32,000 options to buy
@ $1.95, valued at
$62.4k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2021 |
3
| Heyman Tomas J. (Director) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 06/10/2021 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on OptiNose, Inc.|
Txns:
| Granted 14,439 options to buy
@ $3.54, valued at
$51.1k
|
|
| 06/03/2021 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $26.32, valued at
$342.2k
|
|
| 12/04/2020 |
3
| Heyman Tomas J. (Director) has filed a Form 3 on OptiNose, Inc. |
| 12/04/2020 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on OptiNose, Inc.|
Txns:
| Granted 28,879 options to buy
@ $4.05, valued at
$117k
|
|
| 06/11/2020 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $25.04, valued at
$651k
|
|
| 06/11/2020 |
3
| Heyman Tomas J. (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
|
|